Roupen Odabashian

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Roupen Odabashian
May 10, 2025, 17:23 | Insight
Roupen Odabashian reflects on 2025 JAMA study evaluating AI-generated discharge summaries
Roupen Odabashian, Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared a post on LinkedIn: "The…
Apr 24, 2025, 05:45 | Blog
Roupen Odabashian: Doctors are NOT needed?
Roupen Odabashian, Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post on LinkedIn: "Welcome, human…
Apr 14, 2025, 18:39 | Blog
Roupen Odabashian: AI in clinical decision support… Without clinicians?
Roupen Odabashian, Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post on LinkedIn: "AI in…
Apr 11, 2025, 07:05 | Blog
Roupen Odabashian: Excited to be at the Digital health summit event in University of Waterloo, Canada
Roupen Odabashian, Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post on LinkedIn: "Excited to…
Apr 10, 2025, 16:50 | Blog
Roupen Odabashian: Why is Cancer Incidence increasing?
Roupen Odabashian, Hematology/Oncology Fellow at Karmanos Cancer Institute, shared on LinkedIn: "Why is Cancer Incidence…
Apr 4, 2025, 08:37 | Blog
Roupen Odabashian: What founders get wrong about AI agents in healthcare
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute and Podcast Host…
Apr 4, 2025, 06:45 | Blog
Roupen Odabashian: B2B versus B2C in Healthcare - Which Path Will Your Startup Take?
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute and Podcast Host…
Apr 2, 2025, 07:46 | Blog
Roupen Odabashian: Biggest mistakes healthcare founders make
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute and Podcast Host…
Mar 30, 2025, 17:19 | Blog
Roupen Odabashian: Comparing Research Compensation - Healthcare vs AI
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute and Podcast Host…
Mar 28, 2025, 16:39 | Blog
Istvan Petak breaks down Genomate Health’s impact on cancer care with Roupen Odabashian on OncoDaily Dialogues
Genomate Health shared a post on LinkedIn: "In a minute, Dr. Istvan Petak, Founder and…
Mar 22, 2025, 14:55 | Blog
Roupen Odabashian: My ViVE experience
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute and Podcast Host…
Mar 12, 2025, 12:51 | Blog
Roupen Odabashian: The hardest part of being a physician
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute and Podcast Host…
Mar 10, 2025, 14:21 | Blog
Roupen Odabashian: A fantastic dialogue on AI's transformative potential in cancer care with Krissa Smith
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Mar 5, 2025, 06:38 | Dialogues
OncoDaily Dialogues #10 - Krissa Smith / Hosted by Roupen Odabashian
In this episode of OncoDaily Dialogues, Krissa Smith, VP of Education at Susan G. Komen,…
Feb 23, 2025, 10:03 | Blog
Roupen Odabashian: Caroline Zhang’s Journey to Simplify Medicine with AI
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Feb 19, 2025, 03:40 | Blog
Roupen Odabashian: ViVE 2025 – Day 1 Takeaways
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared on LinkedIn:…
Feb 18, 2025, 08:35 | Blog
Roupen Odabashian: Day One at ViVE
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Feb 9, 2025, 17:38 | Blog
Roupen Odabashian: Building a HealthTech Company That Transforms Prostate Cancer Care
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared on LinkedIn: "Missed…
Feb 8, 2025, 07:59 | Blog
Roupen Odabashian: Dietary choices play a crucial role in reducing the risk of colorectal cancer
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared on LinkedIn:…
Feb 5, 2025, 15:11 | Blog
Roupen Odabashian: How ArteraAI is changing prostate cancer treatment through AI-powered diagnostics
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Jan 25, 2025, 16:50 | Blog
Roupen Odabashian: How Helpcare AI is improving patient care by deploying AI agents
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Jan 23, 2025, 20:17 | Blog
Roupen Odabashian: 4th lesson in my online course on how to use AI for learning
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Jan 18, 2025, 22:16 | Blog
Roupen Odabashian: AI Agents Transforming Healthcare
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Jan 16, 2025, 15:46 | Blog
Roupen Odabashian: Why do I see more young patients with cancer?
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Jan 11, 2025, 16:15 | Blog
Roupen Odabashian: The third lesson on using AI for learning
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Jan 9, 2025, 13:25 | Blog
Roupen Odabashian: Maximizing Clinical Documentation with an AI Scribe
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, posted on LinkedIn:…
Jan 6, 2025, 10:41 | Blog
Roupen Odabashian: The second lesson in my series on using AI to enhance learning
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared a post…
Jan 5, 2025, 18:37 | Insight
Roupen Odabashian: How to Study with AI
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared a…
Jan 2, 2025, 16:05 | Blog
Roupen Odabashian: My Wishes for 2025
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared a post…
Jan 1, 2025, 06:02 | Blog
Roupen Odabashian: How to Train your AI scribe
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared a post…
Dec 30, 2024, 13:43 | Insight
Roupen Odabashian: When it comes to real-life cases, physicians still outperform AI
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared a…
Dec 28, 2024, 18:50 | Blog
Roupen Odabashian: Creating and customizing templates for your specific needs with AI scribes
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared a…
Dec 26, 2024, 16:40 | Opinion
Roupen Odabashian: How everyone seems to understand everything
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared a…
Dec 22, 2024, 14:35 | Science
AI scribes don't increase efficiency
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a recent…
Dec 22, 2024, 13:18 | Blog
Roupen Odabashian: Why AI Adoption in Healthcare Trails Behind the Hype
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Dec 22, 2024, 06:04 | Insight
Roupen Odabashian: If you're a health tech startup creating data ask yourself, ‘So what?’
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Dec 17, 2024, 19:56 | Blog
Roupen Odabashian: Beyond LinkedIn and the Bay Area, AI is virtually nonexistent in healthcare
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Dec 16, 2024, 08:02 | Blog
Roupen Odabashian: Revolutionizing healthcare with AI insights from Dyania Health
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post on…
Dec 12, 2024, 11:08 | Blog
Roupen Odabashian: The worst way to present a Healthtech startup pitch or idea
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Dec 10, 2024, 19:12 | Blog
Roupen Odabashian: How physicians should start learning?
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Dec 5, 2024, 22:55 | Blog
Roupen Odabashian: Efficiency and patient privacy drive healthcare adoption
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, posted the following on…
Nov 30, 2024, 10:09 | Blog
Roupen Odabashian: The Emotional Rollercoaster of Oncologists Before the Holidays
Roupen Odabashian shared on LinkedIn: "Wednesday was one of my hardest days as an oncologist. The…
Nov 24, 2024, 08:24 | Blog
Roupen Odabashian: Revolutionizing the Medical-Legal Sector
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, posted on LinkedIn:…
Nov 16, 2024, 11:32 | Blog
Roupen Odabashian: The Tug Between Patient Care and Documentation
Roupen Odabashian, Advisor at Spiraldot Health and Mesh AI, shared on LinkedIn: "In 2010, I began…
Nov 14, 2024, 16:54 | Blog
Roupen Odabashian: Looking for medical students or residents interested in conducting AI research in oncology
Roupen Odabashian, Advisor at Spiraldot Health and Mesh AI, shared on LinkedIn: "Looking for medical…
Nov 8, 2024, 15:58 | Blog
Roupen Odabashian: How AI can enhance literature review and improve patient care at point of care?
Roupen Odabashian, Advisor at Spiraldot Health and Mesh AI, shared a post on LinkedIn: "How…
Nov 6, 2024, 18:17 | Blog
Roupen Odabashian: ChatGPT vs Claude for Cancer patients
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared a post…
Nov 2, 2024, 11:47 | Blog
Roupen Odabashian: ChatGPT is revolutionizing clinical decision support tools!
Roupen Odabashian posted on LinkedIn: "ChatGPT is revolutionizing clinical decision support tools! After using various…
Oct 25, 2024, 18:17 | Blog
Roupen Odabashian: Why Healthcare costs are rising?
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, shared on LinkedIn:…
Oct 23, 2024, 05:17 | Insight
Roupen Odabashian: From Fee-for-Service to Value-Based Care
Roupen Odabashian, Podcast Host at OncoDaily, shared a post on LinkedIn: “From Fee-for-Service to Value-Based…
Oct 9, 2024, 17:29 | Blog
Roupen Odabashian: Fee-for-service harms both patients and physicians
Roupen Odabashian shared on Linkedin: '' Physicians should not be paid for their services! Physicians…
Oct 3, 2024, 18:34 | Blog
Roupen Odabashian: How to prompt Large Language Models
Roupen Odabashian shared on LinkedIn: "Read our latest editorial on how to prompt Large Language…
Sep 26, 2024, 18:07 | Blog
Roupen Odabashian: Is whole body MRI an effective cancer screening tool?
Roupen Odabashian shared a post on LinkedIn: "Is whole body MRI an effective cancer screening…
Sep 18, 2024, 16:34 | Blog
Roupen Odabashian: The ability to measure a marker doesn't equate to clinical benefit
Roupen Odabashian posted on LinkedIn: "The ability to measure a marker doesn't equate to clinical…
Sep 10, 2024, 18:42 | Blog
Roupen Odabashian: Whole-Body MRI: A Comprehensive Approach to Cancer Screening with Growing Potential and Challenges
Roupen Odabashian posted on LinkedIn: "Disclaimer: My name is Roupen, and I am an Oncologist…
Sep 10, 2024, 15:46 | Blog
Roupen Odabashian: Let AI teach you
Roupen Odabashian shared a post on LinkedIn: ''Let AI teach you! I've always been interested…
Sep 6, 2024, 12:30 | Career
Mikkael A. Sekeres, Candidate for Secretary of ASH
Mikkael A. Sekeres, Chair of Committee on Communications at American Society of Hematology (ASH) is…
Sep 5, 2024, 15:15 | Blog
PathwayMD: Revolutionizing Clinical Decision Support with AI Tools
Roupen Odabashian shared a post by Delta: HealthTech Innovators, on LinkedIn: "Clinical decision support _ CDS Review!…
Sep 3, 2024, 17:15 | Blog
Roupen Odabashian: Clinical Decision Augmentation and not support
Roupen Odabashian shared a post on LinkedIn: "Clinical Decision Augmentation and not support. Over the…
Aug 22, 2024, 14:57 | Blog
Roupen Odabashian: Things I learned from meeting physician entrepreneurs
Roupen Odabashian shared a post on LinkedIn: "Things I learned from meeting physician entrepreneurs. Meeting…
Aug 22, 2024, 14:11 | Blog
Roupen Odabashian discussing the current state of AI scribes and Heidi Health with Thomas Kelly
Roupen Odabashian shared a post on LinkedIn by Delta: HealthTech Innovators, adding: "I Had a…
Aug 13, 2024, 13:59 | Blog
Roupen Odabashian: Would you use whole-body MRIs to screen for cancer?
Roupen Odabashian shared a post by Delta: HealthTech Innovators on LinkedIn: "Considering the high cost…
Aug 11, 2024, 07:43 | Blog
Roupen Odabashian: You don't know which lottery ticket you have in life
Roupen Odabashian posted on LinkedIn: "In my work as an oncologist, I often see patients…
Aug 8, 2024, 18:02 | Insight
Discover how technology is transforming cancer care in OncoDaily Dialogue #9 with Istvan Petak and Roupen Odabashian
Genomate Health shared on LinkedIn: "We believe it's time for AI and computational reasoning to…
Aug 8, 2024, 02:16 | Insight
Roupen Odabashian: TalkTastic has exceeded my expectations
Roupen Odabashian shared on LinkedIn: “For years, I searched for an accurate voice-to-text software, and…
Aug 6, 2024, 20:39 | Blog
Roupen Odabashian: Insightful talk on OncoDaily featuring Dr. Matteo Levisetti
Roupen Odabashian shared a post a post by OncoDaily on LinkedIn: "Had an insightful talk on…
Aug 5, 2024, 05:34 | Dialogues
Unlocking the Immune System: Dr. Levisetti on Cue Biopharma's New Biologics
Matteo Levisetti, M.D is chief medical officer of CUE Biopharma which is a clinical-stage biopharmaceutical…
Jul 12, 2024, 21:56 | Blog
Using AI to Screen for Eligibility for Clinical Trials
Roupen Odabashian shared on LinkedIn: "Using AI to Screen for Eligibility for Clinical Trials Manual chart…
Jul 11, 2024, 17:54 | Blog
Roupen Odabashian: Customer Service in Healthcare, Part 2
Roupen Odabashian shared on LinkedIn: "Customer Service in Healthcare, Part 2 Imagine you go to an…
Jul 11, 2024, 16:10 | Blog
Roupen Odabashian: Customer Service in Healthcare
Roupen Odabashian shared a post on LinkedIn: ''Customer Service in Healthcare. Today, for the first time…
Jul 8, 2024, 04:29 | Insight
Roupen Odabashian: The evolution of diagnostic testing
Roupen Odabashian shared a post on LinkedIn about a recent paper by Robert Avram et…
Jun 25, 2024, 01:56 | Blog
Roupen Odabashian: Insurance companies - one of the reasons physicians get burned out
Roupen Odabashian shared a post on LinkedIn: "One of the reasons physicians get burned out! …
Jun 17, 2024, 15:06 | Dialogues
Oncodaily Dialogues #9 István Peták/ Hosted by Roupen Odabashian
In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…
Jun 1, 2024, 08:28 | Blog
Is AI in healthcare hype or real? - Delta: HealthTech Innovators
Roupen Odabashian shared a post by Delta: HealthTech Innovators on LinkedIn, adding the following: “I…
May 28, 2024, 15:08 | Opinion
Roupen Odabashian: We should have a universal test to screen for many cancers at once
Roupen Odabashian shared on LinkedIn: "Every cancer should have a screening test, or let’s put…
May 27, 2024, 12:23 | Blog
Roupen Odabashian: The biggest joy and the biggest frustration in being an oncologist
Roupen Odabashian shared on LinkedIn: "The biggest joy and the biggest frustration in being an…
May 22, 2024, 01:25 | Insight
Roupen Odabashian: The first study of many to come about the use of AI in clinical decision-making in Oncology
Roupen Odabashian shared on LinkedIn: "The amount of publications in oncology is rapidly increasing. As…
May 21, 2024, 03:53 | Blog
Roupen Odabashian: Why Machines or AI Can't Replace Physicians
Roupen Odabashian shared a post on LinkedIn: ''Why Machines or AI Can't Replace Physicians? Many people…
May 19, 2024, 03:40 | Blog
Roupen Odabashian: We are looking for people who are interested in creating a journal club focused on AI in healthcare
Roupen Odabashian shared a post on LinkedIn: "We are looking for medical students, residents, and physicians…
May 14, 2024, 07:02 | Blog
Roupen Odabashian: One of the scariest aspects for me in the Oncology clinic is patients' dates of birth
Roupen Odabashian shared a post on LinkedIn: ''One of the scariest aspects for me in…
May 13, 2024, 05:34 | Insight
Roupen Odabashian: A great episode with Amit Garg from Tau Ventures
Roupen Odabashian shared a post by Delta: HealthTech Innovators on LinkedIn, adding: “This was a…
Apr 30, 2024, 12:12 | Insight
Roupen Odabashian: How cancer treatment decisions are made
Quoting Roupen Odabashian on LinkedIn: "This is another article on how cancer treatment decisions are…
Apr 28, 2024, 15:32 | Blog
Roupen Odabashian: Tool that summarizes patient issues for physicians before their visit
Roupen Odabashian shared on LinkedIn: ''I recently had the chance to use the DeepCura AI nurse…
Apr 27, 2024, 14:57 | Blog
Roupen Odabashian: This was a great interview on OncoDaily with Mikkael Sekeres
Roupen Odabashian shared a post by OncoDaily on LinkedIn, adding: "This was a great interview…
Apr 21, 2024, 06:16 | Dialogues
Oncodaily Dialogues #8 Mikkael Sekeres/ Hosted by Roupen Odabashian
In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…
Apr 17, 2024, 11:09 | Blog
Roupen Odabashian: Have you ever wondered how decisions on cancer treatment are made?
Roupen Odabashian shared on LinkedIn: “Have you ever wondered how decisions on cancer treatment are made?…
Apr 15, 2024, 21:33 | Opinion
Roupen Odabashian: Cancer in Young Adults
Roupen Odabashian shared on LinkedIn: "Cancer in Young Adults One of the most interesting and alarming phenomena…
Apr 15, 2024, 13:36 | Opinion
Roupen Odabashian: Writing medical notes is very subjective: Some AI scribe can help
Roupen Odabashian shared a post on LinkedIn: ''I remember in residency, I spent the first two…
Apr 14, 2024, 12:22 | Blog
Roupen Odabashian: Our platform is seeking passionate and dedicated healthcare professionals
Roupen Odabashian shared a post on LinkedIn: ''Our platform is seeking passionate and dedicated healthcare professionals—including…
Apr 10, 2024, 08:51 | Insight
Roupen Odabashian: Questions asked by one of my patients who is undergoing a bone marrow transplant
Roupen Odabashian, Hematology/Oncology Fellow at Karmanos Cancer Institute and Podcast Host at OncoDaily, shared a…
Apr 8, 2024, 22:18 | Blog
Roupen Odabashian: Healthcare is a crazy place to be in!
Roupen Odabashian, Hematology/Oncology Fellow at Karmanos Cancer Institute and Podcast Host at OncoDaily, shared a…
Apr 8, 2024, 15:34 | Blog
Roupen Odabashian: If nurses are being replaced today what does tomorrow hold?
Roupen Odabashian shared on LinkedIn: "If nurses are being replaced today what does tomorrow hold?…
Apr 6, 2024, 12:43 | Blog
Roupen Odabashian: One of the things many people don't know about me is that I am a war survivor
Roupen Odabashian, Hematology/Oncology Fellow at Karmanos and Podcast Host at OncoDaily, shared a post on…
Apr 4, 2024, 00:51 | Blog
Roupen Odabashian: New article on Delta: HealthTech Innovators on Heidi Health AI scribe tool
Roupen Odabashian shared a post on LinkedIn: “New article on Delta: HealthTech Innovators on Heidi Health…
Apr 2, 2024, 03:23 | Blog
Roupen Odabashian: AI tools that help you find answers to questions in medical literature and provide you with references as well
Roupen Odabashian shared a post on LinkedIn: "Many people use ChatGPT for medical literature, but they…
Mar 23, 2024, 15:29 | Dialogues
OncoDaily Dialogues #7: Aparna Parikh / Hosted by Roupen Odabashian
In our ongoing series called “OncoDaily Dialogues,”we consistently feature prominent individuals in the field of…
Mar 16, 2024, 10:29 | Dialogues
OncoDaily Dialogues #6 – Navneet Singh / Hosted by Roupen Odabashian
In our ongoing series called "OncoDaily Dialogues," we consistently feature prominent individuals in the field…
Feb 16, 2024, 19:15 | Blog
Roupen Odabashian: Live in the moment and enjoy your life
Roupen Odabashian, Hematology and Oncology Fellow at Karmanos Cancer Institute, shared on LinkedIn: “This post…
Jan 21, 2024, 18:34 | Insight
Roupen Odabashian: Can ChatGPT 3.5 assist oncologists in clinical decision-making CMD?
Roupen Odabashian, Hematology and Oncology Fellow at Karmanos Cancer Institute, shared on LinkedIn: "Can ChatGPT…
Jan 12, 2024, 07:07 | Dialogues
OncoDaily Dialogues #5 – Sarkis Meterissian / Hosted by Roupen Odabashian
In our ongoing series called "OncoDaily Dialogues," we consistently feature prominent individuals in the field…
12
All: 114 Posts: 1 - 100
Special Coverage